Skip to main content
. 2023 Mar 29;13:5153. doi: 10.1038/s41598-023-32276-2

Figure 7.

Figure 7

Association of risk signature with common clinical treatments. (AC) Distribution of drug IC50 concentrations in patients in the high-risk group and low-risk group. (D, E) Survival curves of OS (overall survival) and PFI (progression-free interval) in TCGA-LUAD patients receiving chemotherapy. (F, G) Survival curves of OS and PFI in TCGA-LUAD patients receiving radiotherapy. (***p < 0.001; **p < 0.01; *p < 0.05).